We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
-11.48%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$2.63B
AUM Growth
-$644M
Cap. Flow
-$229M
Cap. Flow %
-8.7%
Top 10 Hldgs %
36.43%
Holding
110
New
23
Increased
22
Reduced
18
Closed
21

Top Buys

Rank Stock Value
1
XYZ
Block Inc
XYZ
+$62.1M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$46.1M
3
CP icon
Canadian Pacific Kansas City
CP
+$45.9M
4
FIS icon
Fidelity National Information Services
FIS
+$44M
5
RPRX icon
Royalty Pharma
RPRX
+$43.2M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$147M
2
MSFT icon
Microsoft
MSFT
+$93.8M
3
SPGI icon
S&P Global
SPGI
+$84.8M
4
SCHW
Charles Schwab
SCHW
+$82.9M
5
JNJ icon
Johnson & Johnson
JNJ
+$73.6M

Sector Composition

Rank Sector Weight
1 Healthcare 56.33%
2 Industrials 11.58%
3 Consumer Discretionary 10.43%
4 Technology 7.11%
5 Financials 5.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RPRX icon
1
Royalty Pharma
RPRX
$25.4B
$129M 4.92%
3,078,506
+1,052,896
+52% +$43.2M
UNH icon
2
UnitedHealth
UNH
$383B
$124M 4.71%
240,997
– –
UNP icon
3
Union Pacific
UNP
$176B
$113M 4.31%
532,015
-81,613
-13% -$18.6M
LVS icon
4
Las Vegas Sands
LVS
$30.4B
$97.5M 3.71%
2,903,711
+628,429
+28% +$21.7M
HUM icon
5
Humana
HUM
$47.8B
$92.5M 3.52%
197,668
+8,780
+5% +$3.91M
OTIS icon
6
Otis Worldwide
OTIS
$28.2B
$91.7M 3.49%
1,297,480
– –
IQV icon
7
IQVIA
IQV
$34B
$85.1M 3.23%
392,045
+5,335
+1% +$1.16M
ITCI
8
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$76.4M 2.91%
1,338,700
-193,223
-13% -$11M
EL icon
9
Estee Lauder
EL
$30.3B
$74.6M 2.84%
292,979
-79,496
-21% -$20.2M
KURA icon
10
Kura Oncology
KURA
$948M
$73.6M 2.8%
4,017,000
+123,981
+3% +$1.78M
TPR icon
11
Tapestry
TPR
$28.5B
$68.6M 2.61%
2,247,709
-72,391
-3% -$2.37M
CNC icon
12
Centene
CNC
$32.5B
$68.3M 2.6%
807,438
-389,768
-33% -$32.4M
MA icon
13
Mastercard
MA
$484B
$66M 2.51%
209,111
+18,168
+10% +$6.26M
TMO icon
14
Thermo Fisher Scientific
TMO
$196B
$65.9M 2.51%
121,375
+6,306
+5% +$3.47M
MSFT icon
15
Microsoft
MSFT
$2.99T
$64.2M 2.44%
250,157
-345,590
-58% -$93.8M
V icon
16
Visa
V
$686B
$64M 2.43%
324,818
-113,172
-26% -$23.4M
MRTX
17
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$63.9M 2.43%
951,986
+441,655
+87% +$28.1M
DHR icon
18
Danaher
DHR
$142B
$55.3M 2.1%
246,154
-16,185
-6% -$3.73M
AGIO icon
19
Agios Pharmaceuticals
AGIO
$2.38B
$51.5M 1.96%
2,321,800
+1,144,426
+97% +$25.8M
ACLX
20
DELISTED
Arcellx
ACLX
$44.7M 1.7%
2,470,559
+937,500
+61% +$12.1M
COR icon
21
Cencora
COR
$59.1B
$44.5M 1.69%
314,691
-68,447
-18% -$10.5M
CP icon
22
Canadian Pacific Kansas City
CP
$81.4B
$44.3M 1.68%
+634,056
New +$45.9M
XYZ
23
Block Inc
XYZ
$47.2B
$41.8M 1.59%
+679,676
New +$62.1M
INSM icon
24
Insmed
INSM
$23.2B
$41M 1.56%
2,078,680
+760,248
+58% +$15.9M
VTRS icon
25
Viatris
VTRS
$19.8B
$40.6M 1.55%
+3,881,900
New +$42.6M
1
2 3 4 5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
AA
Alesco Advisors Pittsford, New York $3.92B AUM 15.21% 1-Year Est. Return
DACG
Donor Advised Charitable Giving San Francisco, California $3.92B AUM 59.92% 1-Year Est. Return
CCM
Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Suvretta Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Suvretta Capital Management held 110 positions worth $2.63B, down 20% from $3.27B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Suvretta Capital Management withdrew a net $229M in Q2 2022, closing 21 positions and reducing 18 holdings. Its most notable exit was Amazon, an estimated $147M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, up from 47% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Suvretta Capital Management opened a new position in Block Inc worth $41.8M.

  • Suvretta Capital Management's largest Q2 2022 buy was Block Inc: 679,676 shares worth $41.8M.
  • Suvretta Capital Management added most to Royalty Pharma in Q2 2022, an estimated $43.2M increase.
  • Suvretta Capital Management's biggest Q2 2022 reduction was Microsoft, cutting an estimated $93.8M.
  • Suvretta Capital Management fully exited Amazon in Q2 2022, selling an estimated $147M.
  • Suvretta Capital Management's ten largest holdings make up 36% of its $2.63B portfolio in Q2 2022.
  • Suvretta Capital Management opened 23 new positions and closed 21 in Q2 2022.
  • Suvretta Capital Management's portfolio value fell 20% quarter-over-quarter to $2.63B.

Based on Suvretta Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.